SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

COLOMBO, Gaia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.039
AS - Asia 4.292
EU - Europa 3.015
SA - Sud America 980
AF - Africa 92
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.871
SG - Singapore 1.692
CN - Cina 1.216
BR - Brasile 826
IT - Italia 701
UA - Ucraina 556
HK - Hong Kong 445
DE - Germania 372
TR - Turchia 311
GB - Regno Unito 285
VN - Vietnam 252
PL - Polonia 233
FR - Francia 180
SE - Svezia 171
RU - Federazione Russa 146
FI - Finlandia 136
MX - Messico 90
IN - India 83
ID - Indonesia 72
CA - Canada 66
AR - Argentina 64
NL - Olanda 45
ZA - Sudafrica 44
ES - Italia 43
JP - Giappone 33
GR - Grecia 29
EC - Ecuador 26
IR - Iran 25
PK - Pakistan 25
BD - Bangladesh 24
AT - Austria 21
BE - Belgio 19
IQ - Iraq 19
CO - Colombia 18
AU - Australia 17
IL - Israele 14
CH - Svizzera 13
TN - Tunisia 13
MY - Malesia 12
PE - Perù 12
PT - Portogallo 10
PY - Paraguay 10
VE - Venezuela 10
CL - Cile 9
EG - Egitto 9
KR - Corea 9
LT - Lituania 9
RO - Romania 9
NZ - Nuova Zelanda 8
CZ - Repubblica Ceca 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
TW - Taiwan 6
UZ - Uzbekistan 6
BG - Bulgaria 5
DZ - Algeria 5
IE - Irlanda 4
KE - Kenya 4
BO - Bolivia 3
DK - Danimarca 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
NG - Nigeria 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GT - Guatemala 1
KW - Kuwait 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 17.434
Salva come PNG Salva come JPEG
Città #
Fairfield 998
Woodbridge 956
Singapore 903
Houston 696
Ashburn 671
Jacksonville 621
Chandler 545
Santa Clara 535
Ann Arbor 472
Hong Kong 427
Beijing 376
Wilmington 371
Seattle 366
Cambridge 328
Izmir 243
Warsaw 222
Nanjing 177
Princeton 153
Boardman 100
Ho Chi Minh City 91
Ferrara 90
Los Angeles 90
Dallas 79
San Diego 75
Shenyang 68
São Paulo 59
New York 55
Nanchang 53
Hanoi 50
Mexico City 47
Milan 45
Hebei 44
Tianjin 42
Jakarta 41
Shanghai 41
London 37
Mountain View 34
Redwood City 33
Hefei 31
Moscow 31
Rio de Janeiro 29
Falls Church 28
Jiaxing 28
Bremen 26
Munich 26
Addison 25
Rome 25
Chicago 23
Tokyo 22
Frankfurt am Main 21
Bologna 20
Atlanta 19
Brussels 19
Changsha 19
Columbus 18
Parma 18
Zhengzhou 18
Brooklyn 16
Falkenstein 16
Jinan 16
Poplar 16
The Dalles 16
Haiphong 15
Johannesburg 15
Norwalk 15
Belo Horizonte 14
Brasília 14
Denver 14
Orange 14
San Francisco 14
Helsinki 13
Nuremberg 13
Auburn Hills 12
Council Bluffs 12
Philadelphia 12
Stockholm 12
Verona 12
Boston 11
Buffalo 11
Fortaleza 11
Hangzhou 11
Kunming 11
Manchester 11
Naples 11
Ningbo 11
Vienna 11
Athens 10
Curitiba 10
Da Nang 10
Des Moines 10
Guangzhou 10
Guayaquil 10
Phoenix 10
Porto Alegre 10
Campinas 9
Florianópolis 9
Karachi 9
Lima 9
Mumbai 9
Paris 9
Totale 11.194
Salva come PNG Salva come JPEG
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 335
PRINCIPI DI CALCOLO FARMACEUTICO 294
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 293
Opportunity and challenges of nasal powders: Drug formulation and delivery 265
Biological In Vitro Models for Absorption by Nonoral Routes 247
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 224
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 219
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 216
Respiratory Drug Delivery 191
Design of experiments (DoE) in pharmaceutical development 183
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 182
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 181
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 178
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 176
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 175
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 173
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 171
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 164
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 160
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 155
The use of fatty acids as absorption enhancer for pulmonary drug delivery 155
Skin permeation of 5-methoxypsoralen from topical dosage forms 151
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 151
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 148
null 147
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 147
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 147
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 146
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 145
Alginate and cell combination product for wound healing 143
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 142
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 140
Novel Platforms for Oral Drug Delivery 140
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 139
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 135
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 133
Combination of alginate and cells for skin regeneration 133
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 133
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 132
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 131
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 131
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 129
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 129
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 129
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 129
Formulation Strategies for Antitubercular Drugs by Inhalation 127
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 126
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 126
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 126
Mechanisms of formation and disintegration of alginate beads obtained by prilling 125
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 125
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 122
null 122
Nasal administration and brain targeting of an antiischemic agent 121
Methacholine dry powder inhaler as a new tool for bronchial challenge test 118
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 117
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 117
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 115
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 115
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 112
The role of dissolution test in a comparison of generic and branded controlled-release products 109
Single layer dermal patch: skin accumulation assessed by tape stripping 108
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 106
null 106
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 102
In vitro and in vivo study of a desmopressin nasal powder 101
Spray therapeutic paint for topical treatment of orf virus skin infections in breeding sheep 101
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 101
null 101
Film for active ingredients dermal and transdermal administration 101
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 101
null 100
null 97
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 97
null 96
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 96
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 96
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 95
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 95
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 95
Strategies in bupivacaine delivery for prolonged duration local anesthesia 94
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 94
Nasal powders of morphine microcrystals agglomerates 94
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 94
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 93
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 93
Development of artemisinin - β-cyclodextrin complex agglomerates 92
Study of a Sucralfate gel-based therapeutic paint for antiviral drug topical application by spraying 92
Development of a spray-dried powder for nasal administration of desmopressin acetate 91
In vitro comparison of four anti-inflammatory topical medications 91
null 91
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 90
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 90
Use of sucralfate gel as a vehicle for topical administration of the antiviral drug cidofovir 90
Nose-to-brain delivery of ribavirin (RBV) for the treatment of viral encephalitis 90
Construction of amikacin dry powders for inhalation by a Central Composite Design 89
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 89
Produzione e caratterizzazione di nanoparticelle ottenute dall'interazione ionica tra lecitina e chitosano 88
Desmopressin Dry Powder for Nasal Administration 88
null 88
Totale 13.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.034
Totale 82.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.185 0 0 0 0 0 151 182 210 74 280 188 100
2021/20221.265 51 154 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/20252.881 93 46 229 87 433 317 173 165 445 344 301 248
2025/20263.839 561 435 730 1.059 939 115 0 0 0 0 0 0
Totale 17.675